Dr. Woeber is the Harris M. Fishbon Professor of Clinical Medicine at UCSF. He received his MD from the University of the Witwatersrand, Johannesburg and is a Fellow of the Royal College of Physicians of Edinburgh. He served a Research Fellowship in Endocrinology at the Thorndike Memorial Laboratory in the Harvard Medical Unit at Boston City Hospital. He is certified by the American Board of Internal Medicine and by its subspecialty board in Endocrinology. Dr. Woeber is the recipient of the Van Meter Prize of the American Thyroid Association. He served on the Board of Directors of the American Board of Internal Medicine and was Chairman of the Subspecialty Board on Endocrinology and Metabolism.

His current research is concerned with the potential use of redifferentiating drugs in the management of aggressive thyroid cancer, with the factors that regulate peripheral thyroid hormone metabolism, and with the natural history of subclinical hyperthyroidism.

Recent publications

• Triiodothyrome production in Graves hyperthyroidism Thyroid 2006; 16: 687-690.
• Observations concerning the natural history of subclinical hyperthyroidism. Thyroid 2005: 15: 687-691.
• Graves' ophthalmology after radiation treatment of thyroid cancer. Endocr Pract 2008; 14: 419-421.
• Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations. J Endocrinol Invest 2002; 25:106-109.
• Update on the management of hyperthyroidism and hypothyroidism. Arch Int Med 2000; 160:1067-1071.